Interleukin inhibitors

Skyrizi 150 mg/mL single-dose prefilled pen Images

Generic Name: risankizumab

This medication has been identified as Skyrizi 150 mg/mL single-dose prefilled pen. It is supplied by AbbVie Inc.

Skyrizi is used in the treatment of Crohn's Disease; Psoriatic Arthritis; Plaque Psoriasis; Psoriasis and belongs to the drug class interleukin inhibitors. Skyrizi 150 mg/mL single-dose prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).

Images

Skyrizi (Risankizumab [ ris-an-kiz-ue-mab ])-medicine-150 mg/mL single-dose prefilled pen

Skyrizi
Generic Name: risankizumab [ ris-an-kiz-ue-mab ]
Imprint: medicine
Strength: 150 mg/mL single-dose prefilled pen
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Interleukin inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00074-2100
Inactive Ingredients:
Latest News
Related Drugs